EP
RXST icon

Essential Partners’s RxSight RXST Stock Holding History

Essential Partners’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.12K Buy
1,891
+1,467
+346% +$8.86K ﹤0.01% 1254
2026
Q1 		$2.61K Buy
424
+314
+285% +$2.61K ﹤0.01% 1893
2025
Q4 		$1.15K Buy
110
+108
+5,400% +$1.08K ﹤0.01% 1987
2025
Q3 		$18 Sell
2
-7
-78% -$61 ﹤0.01% 2641
2025
Q2 		$117 Buy
+9
New +$135 ﹤0.01% 2043

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Essential Partners's RXST Position: Q2 2026 in Review

Essential Partners increased its RxSight (RXST) stake by 346% in Q2 2026, buying an estimated $8.86K and bringing the position to 1,891 shares worth $9.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Essential Partners first reported a position in RXST in Q2 2025 and has held it in 5 quarters since. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Essential Partners held 1,891 shares of RxSight worth $9.12K as of Q2 2026.
  • Essential Partners bought 1,467 RxSight shares in Q2 2026, an estimated $8.86K.
  • RxSight made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1254 holding.
  • Essential Partners first reported a position in RxSight in Q2 2025 and has held it in 5 quarters since.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.